About
European Corona Vaccine Trial Accelerator Platform
VACCELERATE is a pan-European backbone accelerating phase 2 & 3 COVID-19 vaccine trials. The overall objective of VACCELERATE is to connect all European stakeholders involved in vaccine development to provide a pan-European platform for clinical trial design and conduct. VACCELERATE constitutes the rapid response single entry-point to stakeholders from public health authorities to vaccine developers, to address respective needs and kick-start specifically phase 2 & 3 vaccine trials.
Start Date: 28 January 2021
End Date: 27 January 2024
Funding Agency: European Union
Coordinator: University of Cologne
Total Funding: € 12 Mio
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views
- Comments 0